Clinical Trial Update: Relative Bioavailability Study of Phase III Tablet Formulation of Cabotegravir [Phase 1]

View source ↗

Summary

This clinical trial update reports the completion of a relative bioavailability study for a Phase III tablet formulation of cabotegravir, sponsored by ViiV Heal…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• cabotegravir (cabotegravir)

Snippet

Sponsor: ViiV Healthcare | Conditions: Infection, Human Immunodeficiency Virus | Phase 1 | Status: COMPLETED